SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

AstraZeneca’s Ultomiris Approved; Zegfrovy Launched

The headline reports approval of AstraZeneca’s Ultomiris and the launch of Zegfrovy.

AZN